CXCL12 and glioblastoma: Notably, the application of cycloheximide (CHX), a protein synthesis inhibitor, resulted in the accumulation of GLI1 protein levels in SDF-1α-treated GBM cells, thereby highlighting an additional layer of complexity regarding the post-translational modification of GLI1 in GBM (Figure 5A).